Seiji Yamamoto Selected Research

Ligation

3/2010	Up-regulation of histamine H4 receptors contributes to splenic apoptosis in septic mice: counteraction of the antiapoptotic action of nuclear factor-kappaB.
1/2010	Increased death receptor pathway of apoptotic signaling in septic mouse aorta: effect of systemic delivery of FADD siRNA.
10/2009	Nuclear factor-kappaB decoy oligodeoxynucleotides ameliorate impaired glucose tolerance and insulin resistance in mice with cecal ligation and puncture-induced sepsis.
5/2009	Silencing of fas-associated death domain protects mice from septic lung inflammation and apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seiji Yamamoto Research Topics

Disease

28	Neoplasms (Cancer) 02/2024 - 08/2002
11	Inflammation (Inflammations) 01/2020 - 12/2008
8	Sepsis (Septicemia) 05/2012 - 12/2008
7	Glioma (Gliomas) 01/2016 - 11/2005
5	Fibrosis (Cirrhosis) 11/2022 - 03/2016
5	Insulin Resistance 01/2020 - 10/2009
4	Obesity 11/2020 - 01/2017
4	Carcinoma (Carcinomatosis) 06/2009 - 01/2005
3	Stroke (Strokes) 01/2021 - 03/2016
3	Hemorrhage 10/2019 - 01/2016
3	Ischemia 01/2018 - 11/2003
3	Infarction (Infarctions) 02/2012 - 03/2007
3	Neoplasm Metastasis (Metastasis) 01/2012 - 10/2004
3	Infections 01/2012 - 12/2005
3	Brain Neoplasms (Brain Tumor) 12/2009 - 11/2005
3	Cerebral Infarction 10/2009 - 09/2004
2	Metabolic Diseases (Metabolic Disease) 01/2023 - 01/2021
2	Disease Progression 01/2021 - 07/2020
2	Vascular Remodeling 11/2020 - 01/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 11/2005
2	Glucose Intolerance 01/2020 - 10/2009
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019 - 10/2009
2	Carcinogenesis 05/2017 - 03/2006
2	Hypoxia (Hypoxemia) 12/2016 - 02/2011
2	Glioblastoma (Glioblastoma Multiforme) 01/2016 - 01/2015
2	Squamous Cell Carcinoma of Head and Neck 03/2011 - 06/2009
2	Brain Ischemia (Cerebral Ischemia) 07/2010 - 10/2009
2	Septic Shock (Toxic Shock Syndrome) 01/2010 - 12/2008
2	Embolism (Embolus) 03/2007 - 09/2004
2	Hearing Loss (Hearing Impairment) 01/2005 - 01/2005
1	Cachexia 02/2024
1	Dyspnea (Shortness of Breath) 02/2024
1	Atopic Dermatitis (Atopic Eczema) 12/2023
1	Colorectal Neoplasms (Colorectal Cancer) 11/2023
1	Nausea 09/2023
1	Vomiting 09/2023
1	Cystic Lymphangioma (Hygroma) 11/2021
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2021
1	Demyelinating Diseases (Demyelinating Disease) 01/2021

Drug/Important Bio-Agent (IBA)

5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 11/2003
5	CytokinesIBA 01/2018 - 10/2004
4	Proteins (Proteins, Gene)FDA Link 12/2023 - 12/2008
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 10/2009
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2021 - 01/2016
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 03/2016
3	Platelet-Derived Growth FactorIBA 05/2020 - 01/2016
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2020 - 02/2004
3	Becaplermin (PDGF-BB)FDA Link 05/2018 - 03/2011
3	Neuroprotective AgentsIBA 01/2018 - 10/2009
3	OligodeoxyribonucleotidesIBA 03/2010 - 10/2004
3	Ganciclovir (Cytovene)FDA LinkGeneric 12/2009 - 03/2003
3	Thymidine KinaseIBA 12/2009 - 03/2003
3	Interleukin-12 (IL 12)IBA 01/2005 - 10/2004
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2005 - 02/2004
2	Opioid Analgesics (Opioids)IBA 02/2024 - 09/2023
2	Oxycodone (Oxycontin)FDA LinkGeneric 02/2024 - 09/2023
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2016
2	Sirtuin 1IBA 09/2018 - 01/2018
2	NestinIBA 05/2018 - 02/2012
2	Hematoxylin (Haematoxylon)IBA 01/2018 - 01/2016
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2018 - 01/2016
2	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2017 - 03/2016
2	Tamoxifen FDA LinkGeneric 01/2017 - 03/2016
2	Coloring Agents (Dyes)IBA 01/2016 - 07/2010
2	Peptide Hydrolases (Proteases)FDA Link 07/2015 - 01/2010
2	Insulin (Novolin)FDA Link 06/2011 - 10/2009
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 02/2011 - 12/2008
2	NF-kappa B (NF-kB)IBA 03/2010 - 10/2009
2	Small Interfering RNA (siRNA)IBA 01/2010 - 08/2005
2	SiliconesIBA 03/2007 - 09/2004
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2006 - 11/2005
2	Cisplatin (Platino)FDA LinkGeneric 08/2005 - 01/2005
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2005 - 01/2005
2	AntigensIBA 01/2005 - 01/2005
2	DNA (Deoxyribonucleic Acid)IBA 02/2004 - 08/2002
1	Morphine (MS Contin)FDA LinkGeneric 02/2024
1	Fentanyl (Sublimaze)FDA LinkGeneric 02/2024
1	Interleukin-13IBA 12/2023
1	InterleukinsIBA 12/2023
1	Filaggrin ProteinsIBA 12/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2023
1	TabletsIBA 09/2023
1	AntiemeticsIBA 09/2023
1	PlasticsIBA 01/2023
1	FollistatinIBA 11/2022
1	AmphiregulinIBA 11/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021
1	Collagen Type I (Type I Collagen)IBA 01/2021

Therapy/Procedure

12	Therapeutics 07/2020 - 03/2003
4	Drug Therapy (Chemotherapy) 11/2023 - 08/2005
4	Ligation 03/2010 - 05/2009
4	Punctures 03/2010 - 05/2009
4	Radiotherapy 02/2006 - 01/2005
2	Immunotherapy 01/2012 - 10/2004
2	Intra-Arterial Infusions 03/2011 - 06/2009
2	Lasers (Laser) 12/2006 - 11/2005
2	Photochemotherapy (Photodynamic Therapy) 12/2006 - 11/2005
1	Occupational Therapy (Therapy, Occupational) 01/2021
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2021
1	Thrombolytic Therapy 01/2021